Alpine Global Management, LLC Clovis Oncology, Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.43 - $3.14 $65,765 - $144,408	-45,990 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $124,173 - $218,912	45,990 New	45,990 $125,000
Q1 2020 Apr 09, 2020	SELL	$3.77 - $11.0 $139,203 - $406,164	-36,924 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$3.0 - $16.43 $110,772 - $606,661	36,924 New	36,924 $385,000
Q3 2018 Nov 15, 2018	SELL	$29.37 - $49.48 $219,247 - $369,368	-7,465 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.06 - $62.4 $313,977 - $465,816	7,465 New	7,465 $339,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.